Hovid Marketing Sdn. Bhd. is a wholly-owned subsidiary of Hovid Bhd. It markets health and wellness products through the network marketing business channel.

The Hovid Group's pharmaceutical division manufactures and markets more than 300 different types of ethical drugs , health and dietary supplements. Hovid's product categories are divided into pharmaceutical ethical, dietary supplements, injections and consumer products.

The Hovid Group's range of principal products and activities include:

• special drug delivery systems, such as modified release formulations and bio-availability enhanced formulations;
• ethical products, including anti-biotics, anti-diabetics, anti-hypertensives, anti-malarial and anti-inflammatory analgesics;
• dietary supplements;
• consumer products; and
• the commercial extraction of palm tocotrienol complex, mixed carotenoid complex and phytosterols from palm fruits .

Hovid's manufacturing facilities and practices in respect of its pharmaceutical products conform to the PIC/S' GMP and Good Laboratory Practice Standards.

Hovid's strength lies in its export market which extends to over 30 countries around the world.Hovid also prides itself of being the first to introduce Malaysian generic drugs overseas, specifically Philippines and Cambodia. It has successfully registered 500 products in 26 different countries worldwide.

Hovid's subsidiary, Carotech produces and markets full-spectrum tocotrienol complex, mixed carotene complex and phytosterol products. Carotech exports to 27 countries worldwide. Its wholly owned subsidiary Carotech Inc based in New Jersey, USA, is responsible for the marketing and distribution of Carotech's products in U.S.A. The U.S. represents the largest market for Carotech's products, accounting for 52% of Carotech's total exports.